Cited skincare — every flag names its source, no upsell.
Ar

Argireline

Acetyl Hexapeptide-8Active

Signal peptide marketed as a topical alternative to injectable neurotoxins. Effects are mild and gradual at best.

What it does

Argireline is a synthetic hexapeptide that interferes with neurotransmitter release in vitro — the basis for the 'topical Botox' marketing. Real-world skin penetration is limited and the in-vivo effect, where it exists, is subtle. Brand-funded studies report modest improvements in expression-line depth over 8–12 weeks; independent replication is thin. Reasonable to include as part of a peptide stack; not a substitute for an injectable neurotoxin.

The evidence, graded

strongMost cosmetic peptides (Matrixyl, copper peptides, palmitoyl tripeptide-1) show measurable firmness or elasticity changes in 8–12 weeks of consistent twice-daily use. Visible benefits are typically subtle compared to retinoids.Robinson 2005 · International Journal of Cosmetic Science
expert consensusPeptides support collagen production through pathways distinct from retinoids. Combining the two can compound anti-aging benefits without compounding irritation.Mukherjee 2006 · Clinical Interventions in Aging
emergingSome peptides are pH-sensitive and may degrade in acidic environments (low-pH AHA, BHA, or L-ascorbic acid). Apply at separate steps with a wait, or split into different times of day for stability.Errante 2020 · Frontiers in Chemistry

Graded per the methodology: strong · moderate · emerging · expert consensus. A weak source on a strong claim gets the weaker label.

Also known as

acetyl hexapeptide-8, acetyl hexapeptide-3

Pairs worth knowing

Browse all 668 ingredients — grouped by what they do, each with whatever evidence we can cite.

This page is public so a shared ingredient card always has its sources behind it — and so you can check them without an account.
Want more like this?
Every evidence-based flag cites its source, Drop tells you when your routine is complete, and it helps you simplify — instead of selling you more. The app launches on iOS and Android in October 2026. Rate my routine works today at /rate — no sign-in.